Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer (Q38075218)
Jump to navigation
Jump to search
scientific article published on 16 January 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer |
scientific article published on 16 January 2013 |
Statements
1 reference
Preclinical rationale for PI3K/Akt/mTOR pathway inhibitors as therapy for epidermal growth factor receptor inhibitor-resistant non-small-cell lung cancer (English)
1 reference
Shirish M Gadgeel
1 reference
Antoinette Wozniak
1 reference
16 January 2013
1 reference
1 reference
14
1 reference
4
1 reference
322-332
1 reference
1 reference
Identifiers
1 reference
1 reference